Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)

Karam Khaddour; Joshua Dowling; Jiayi Huang; Martha Council; David Chen; Lynn Cornelius; Tanner Johanns; Sonika Dahiya; George Ansstas

doi:10.18632/oncotarget.28365

Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)

Karam Khaddour, Joshua Dowling, Jiayi Huang, Martha Council, David Chen, Lynn Cornelius, Tanner Johanns, Sonika Dahiya, George Ansstas

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	126
Number of pages	1
Journal	Oncotarget
Volume	14
DOIs	https://doi.org/10.18632/oncotarget.28365
State	Published - Feb 11 2023

Access to Document

10.18632/oncotarget.28365

Cite this

Khaddour, K., Dowling, J., Huang, J., Council, M., Chen, D., Cornelius, L., Johanns, T., Dahiya, S., & Ansstas, G. (2023). Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget). Oncotarget, 14, 126. https://doi.org/10.18632/oncotarget.28365

@article{dcc87559a4d0409cb82b382a7cc7cde5,

title = "Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)",

author = "Karam Khaddour and Joshua Dowling and Jiayi Huang and Martha Council and David Chen and Lynn Cornelius and Tanner Johanns and Sonika Dahiya and George Ansstas",

year = "2023",

month = feb,

day = "11",

doi = "10.18632/oncotarget.28365",

language = "English",

volume = "14",

pages = "126",

journal = "Oncotarget",

issn = "1949-2553",

}

Khaddour, K, Dowling, J , Huang, J , Council, M, Chen, D, Cornelius, L , Johanns, T , Dahiya, S & Ansstas, G 2023, 'Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)', Oncotarget, vol. 14, pp. 126. https://doi.org/10.18632/oncotarget.28365

TY - JOUR

T1 - Erratum

T2 - Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)

AU - Khaddour, Karam

AU - Dowling, Joshua

AU - Huang, Jiayi

AU - Council, Martha

AU - Chen, David

AU - Cornelius, Lynn

AU - Johanns, Tanner

AU - Dahiya, Sonika

AU - Ansstas, George

PY - 2023/2/11

Y1 - 2023/2/11

UR - http://www.scopus.com/inward/record.url?scp=85148113251&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.28365

DO - 10.18632/oncotarget.28365

M3 - Comment/debate

C2 - 36780317

AN - SCOPUS:85148113251

SN - 1949-2553

VL - 14

SP - 126

JO - Oncotarget

JF - Oncotarget

ER -

Erratum: Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation (Oncotarget)

Access to Document

Other files and links

Cite this